Cyclosporine improves psoriasis in a double-blind study.
Cyclosporine improves psoriasis in a double-blind study.
复制标题
在一项双盲研究中,环孢素可改善牛皮癣。
DOI:
10.1001/jama.1986.03380220076026
复制
发表时间:
1986
期刊:
影响因子:
--
通讯作者:
J. Voorhees
中科院分区:
文献类型:
--
作者:
C. Ellis;D. C. Gorsulowsky;T. Hamilton;J. Billings;Marc D. Brown;J. Headington;K. Cooper;O. Baadsgaard;E. Duell;T. Annesley;J. Turcotte;J. Voorhees
In a double-blind trial, 21 patients with severe plaque psoriasis were randomly assigned to receive oral cyclosporine, 14 mg/kg/d, or its vehicle. After four weeks of therapy the 11 cyclosporine recipients had the following response to treatment: two had total clearing and six improved markedly, two moderately, and one minimally; whereas ten vehicle-treated patients showed no change or minimal improvement. Vehicle-treated patients, after a switch to cyclosporine for four weeks, demonstrated impressive improvement similar to that seen in patients who initially received only cyclosporine. Moderate or marked improvement or total clearing was noted in 17 (81%) of 21 and 20 (95%) of 21 after one and four weeks of therapy, respectively. Mitotic figures and leukotriene B4 levels in lesions decreased 86% and 64%, respectively, after seven days of cyclosporine therapy. Mononuclear (including activated T cells) and polymorphonuclear leukocyte infiltrates were markedly reduced in lesions of all patients after seven days of cyclosporine therapy. These results suggest that psoriasis may have an immunologic basis mediated by activated T cells and/or other immune cells; if a long-term regimen with a favorable efficacy-side effect ratio can be determined, cyclosporine would be a significant advance in the treatment of psoriasis.